期刊文献+

老年患者靶控输注瑞芬太尼和丙泊酚的临床评价 被引量:23

Target-controlled infusions of remifentanil and propofol in elderly patients
下载PDF
导出
摘要 目的:探讨老年患者靶控输注(target-controlled infusion,TCI)不同血浆浓度瑞芬太尼和丙泊酚的临床安全性和可行性,并评价Marsh参数应用于老年人丙泊酚TCI系统的性能。方法:30例老年患者,随机分为三组,每组10例。A组,丙泊酚复合硬膜外组;B组,丙泊酚复合瑞芬太尼(血浆浓度4μg/L)组;C组,丙泊酚复合瑞芬太尼(血浆浓度7μg/L)组。3组病例丙泊酚TCI的血浆浓度均为3mg/L。观察患者麻醉及术中的脑电双频指数(bispetralindex,BIS)、心率、血压、心率变异性等指标,并抽取桡动脉血,检测丙泊酚的血浆浓度。结果:(1)B,C组(血浆浓度4,7μg/L)的瑞芬太尼能有效抑制插管反应,但C组(血浆浓度7μg/L)麻醉诱导时低血压和窦缓的几率增加;(2)3组患者术中均能维持足够的麻醉深度(BIS值=45~60);(3)瑞芬太尼联合丙泊酚TCI不影响老年患者的苏醒;(4)Marsh参数的丙泊酚TCI系统用于我国老年患者偏离性(MDPE)为11.17%、精确度(MDAPE)为12.16%。结论:血浆浓度4,7μg/L的瑞芬太尼联合丙泊酚麻醉均能安全应用于老年患者的临床麻醉,但应用血浆浓度7μg/L的瑞芬太尼在麻醉诱导时应注意加强监测。采用Marsh参数的丙泊酚TCI系统可安全有效地应用于我国老年患者。 Objective: To investigate the clinical reliability and feasibility of target-controlled infusion (TCI) with different plasm concentration remifentanil and propofol. Methods: Thirty ASA Ⅰ-Ⅱ patients, ≥65 years old, undergoing selective lower abdominal operation were divided into 3 groups, group A with anesthesia using propofol combined with epidural block, group B with anesthesia using propofol and remifentanil (plasm concentration 4μg/L), group C with anesthesia using propofol and remifentanil (plasm concentration 7 μg/L). BIS value, heart rate, blood pressure, heart rate variability and so on, were recorded during anesthesia and operation. Radial arterial blood samples for analysis of plasma concentration of propofol were taken during operation. Results: ( 1 ) The intubation response of groups B and C was lower than that of group A . (2) The depth of anesthesia was enough during operation ( BIS value =45 -60). (3) TCI propofol combined with remifentanil didn't lengthen the awaking time of patients; (4) MDPE of target-controlled infusion using propofol with Marsh parameters was 11.17% , MDAPE was 12.16% in Chinese elderly patients. Conclusion: Remifentanil with plasma concentration of 4 and 7 μg/L combined with propofol could be safely used during clinical anesthesia of old patient, but monitoring must be strengthened during induction when plasma concentration of remifentanil was 7 μg/L. TCI propofol with Marsh parameters could be applied to Chinese elderly patients safely and efficently.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期513-515,共3页 Journal of Peking University:Health Sciences
关键词 丙泊酚 瑞芬太尼 麻醉 静脉 老年人 Propofol Remifentanil Anesthesia,intravenous Aged
  • 相关文献

参考文献9

  • 1Tzabar Y, Brydon C, Gillies GWA. Induction of anaesthesia with midazolam and a target-controlled propofol infusion[J]. Anaesthesia, 1996, 51: 536-538
  • 2Nieuwenhuyzen MC, Engbers FH, Vuyk J, et al. Target controlled infusion systems in anaesthesia and analgesia[J]. Clin Pharmacokinet, 2000, 38: 181-190
  • 3Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients[J]. Anesthesiology, 1998, 89: 562-573
  • 4Sielenkamper AW, Booke M. Anaesthesia and the elderly[J]. Curr Opin Anaesthesiol, 2001, 14: 679-684
  • 5Johannsen EK, Manro AJ. Remifentanil in emergency caesarean section in pre-eclampsia complicated by thrombocytopenia and abnormal liver function[J]. Anesth Intensive Care, 1999, 27: 527-529
  • 6Servin FS. Remifentanil: an update[J]. Curr Opin Anaesthesiol, 2003, 16: 367-372
  • 7Vuyk J, Lim T, Engbers FHM, et al. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients[J]. Anesthesiology, 1995, 83: 8-22
  • 8张马忠,王珊娟,杭燕南,吴健.靶控输注异丙酚的临床应用和准确性评价[J].中华麻醉学杂志,2002,22(11):660-663. 被引量:56
  • 9于布为,彭章龙,赵永泉.高龄病人异丙酚分步TCI时效应室浓度及BIS的变化[J].中华麻醉学杂志,2002,22(12):711-714. 被引量:44

二级参考文献20

  • 1Alvis JM, Reves JG, Govier AV, et al. Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: comparison with a manual method. Anesthesiology, 1985, 63: 41-49.
  • 2Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth, 1991, 67:41-48.
  • 3Veselis PA, Glass P, Danistrian A, et al. Performance of computerassisted continuous infusion at low concentration of intravenous sedatives. Anesth Analg, 1997, 87: 1045-57.
  • 4Schüttler J, Ihmsen H. Population pharmacokinetic of propofol.Anesthesiology, 2000, 92: 727-738.
  • 5Short TG, Lim TA, Tam YH. Prospective evaluation of pharmacokinetic model-controlled infusion of propofol in adult patients.BrJ Anaesth, 1996, 76: 313-315.
  • 6Irwin MG, Thompson N, Kenny NC. Patient-maintained propofol sedation: assessment of a target-controlled infusion system.Anaesthesia, 1997, 52: 525-530.
  • 7Kazama T, Ikeda K, Morita K. Reduction by fentanyl of Cp50Values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology, 1997; 87: 213-217.
  • 8Sharer A, Doze VA, Shafer SL, et al. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.Anesthesiology, 1988, 69: 348-356.
  • 9Shafer SL, Siegel LC, Cooke James, et al. Testing computercontrolled infusion pumps by simulation. Anesthesiology, 1988,68: 261-266.
  • 10Zomorodi K, Donner A, Somma J, et al. Population pharmacokinetics of midazolam administration by target controlled infusion for sedation following coronary artery bypass grafting.Anesthesiology, 1998, 89: 1418-1429.

共引文献95

同被引文献210

引证文献23

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部